Field efficacy of fluralaner (Bravecto® chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs
暂无分享,去创建一个
R. Farkas | D. Rapti | M. Leschnik | R. Chiummo | E. Zschiesche | Rezart Postoli | B. Capári | Mathieu Chiquet | Alain Audry
[1] R. Farkas,et al. Babesiosis in Southeastern, Central and Northeastern Europe: An Emerging and Re-Emerging Tick-Borne Disease of Humans and Animals , 2022, Microorganisms.
[2] D. Modrý,et al. The distribution of Dermacentorreticulatus in the Czech Republic re-assessed: citizen science approach to understanding the current distribution of the Babesiacanis vector , 2022, Parasites & vectors.
[3] Dorothy Normile,et al. Flea and tick treatment satisfaction, preference, and adherence reported by cat owners in the US, UK, or France who treated their cats with transdermal fluralaner , 2021, Open veterinary journal.
[4] A. Bajer,et al. Monitoring the expansion of Dermacentor reticulatus and occurrence of canine babesiosis in Poland in 2016–2018 , 2021, Parasites & Vectors.
[5] Leschnik Michael. Focus on Common Small Animal Vector-Borne Diseases in Central and Southeastern Europe , 2020 .
[6] Peter J. Krause. Human babesiosis. , 2019, International journal for parasitology.
[7] A. Estrada-Peña,et al. A review of canine babesiosis: the European perspective , 2016, Parasites & Vectors.
[8] H. Sprong,et al. Dermacentor reticulatus: a vector on the rise , 2016, Parasites & Vectors.
[9] Janina Taenzler,et al. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution , 2016, Parasites & Vectors.
[10] B. Carcy,et al. Classification of Babesia canis strains in Europe based on polymorphism of the Bc28.1-gene from the Babesia canis Bc28 multigene family. , 2015, Veterinary parasitology.
[11] Janina Taenzler,et al. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™) , 2015, Parasites & Vectors.
[12] C. Ducrot,et al. Questionnaire-based survey on the distribution and incidence of canine babesiosis in countries of Western Europe , 2014, Parasite.
[13] C Barbui,et al. What is the European Medicines Agency? , 2012, Epidemiology and Psychiatric Sciences.
[14] P. Irwin. Canine babesiosis: from molecular taxonomy to control , 2009, Parasites & Vectors.
[15] L. Papp,et al. Clinical manifestations of canine babesiosis in Hungary (63 cases). , 2006, Acta veterinaria Hungarica.
[16] H. Mehlhorn,et al. Electron microscopical studies on the development of Babesia canis (Sporozoa) in the salivary glands of the vector tick Dermacentor reticulatus. , 1979, Acta tropica.
[17] Guideline on statistical principles for veterinary clinical trials , 2010 .
[18] H. Sager,et al. Presence of potentially pathogenic Babesia sp. for human in Ixodes ricinus in Switzerland. , 2006, Annals of agricultural and environmental medicine : AAEM.
[19] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[20] P. Hillyard. Ticks of North-West Europe. , 1996 .